JENNIFER TROMBATORE: Open Payments
NPI 1346893732 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,618 in 90 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $692 · 2025 $1,618
Food & beverage: $1,618
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 10 | $271 |
| AstraZeneca Pharmaceuticals LP | 11 | $226 |
| ABBVIE INC. | 14 | $193 |
| Novo Nordisk Inc | 12 | $182 |
| Lilly USA, LLC | 6 | $114 |
| Dexcom, Inc. | 5 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $88 |
| Axsome Therapeutics, Inc. | 4 | $70 |
| Exact Sciences Corporation | 3 | $61 |
| Amgen Inc. | 3 | $54 |
Products named: GEMTESA, BREZTRI, QULIPTA, Dexcom G6 Transmitter, CAPLYTA, Ozempic, Auvelity, Wegovy.
Industry payments across LA — which companies pay providers there.
